Categories
drugs healthcare

Big Pharma Greed: Monetary Manipulation

On the surface, it may sometimes look like drug companies are doing good things with their money and trying to improve the society that consumes their products. Nestle, a candy company based in Switzerland, is partnering with a drug company to provide its food engineering expertise in a joint effort to make medicines taste good. […]

Categories
drugs healthcare

Big Pharma Greed: Dirty Drug Patents

Moderna is a drug company that’s been very secretive about what product they’re developing. The startup claims to be working on a new class of drugs that manipulate antibodies into producing drugs via therapeutic proteins (Vardi, 2016). It wasn’t until Acuitas filed a lawsuit in British Columbia that Moderna revealed exactly what they’re working on. […]

Categories
drugs healthcare

Big Pharma Greed: Monetary Settlements

With all of the settlements that Big Pharma has to pay, one might conclude that the industry is not stable enough to support itself; however, drug companies are experiencing growth and are commonly found on the Fortune 500 List (Law, 2006). According AlterNet, “Pharmaceutical companies have been hit with $14.8 billion in wrongdoing settlements in […]

Categories
diversity

Diversity Nomenclature

What is the benefit and/or harm of using increasingly specific classifications to identify subpopulations of diverse people? Is the use of one umbrella term more effective and inclusive? Diverse communities of people are not monolithic. Subpopulations of diverse people can flourish within diverse environments which gives way to an exponential growth in our classification lexicon. […]

Categories
healthcare

Social Determinants of Health

Although there are lots of physical, tangible diseases that cause people to become ill, there is a single disease that is intangible, not quantifiable, but no less lethal. It’s called Life Sucks Disease (LSD). People commonly accept the notion that high blood pressure, high cholesterol, and diabetes can kill us. But what about all of […]

Categories
business

Business Law and Regulatory Pressures: Doing What You Believe In

Modern business practices suggest that GE should separate all of its product lines into many small businesses. Welch refused to do so. Even while hospitalized, he remained adamant that he did not want GE’s diverse portfolio broken up. In the end, GE was successful partly due to Welch’s defiance of the status quo. Welch’s initiatives […]

Categories
business

Business Law and Regulatory Pressures: International Operations

Companies looking to gain space in markets oversees need to be aware of local laws and regulations that are applicable to their industry. Companies that operate in China are subject to local laws and need to pay close attention to anti-bribery laws. GlaxoSmithKline is a multinational drug company that employs 100,000 people around the world […]

Categories
business

BOGSAT Phenomenon

A “bunch of guys sitting around and talking”. This is not just a common occurrence in everyday life; this is an important business phenomenon. It is not enough for leaders to act as cogs in a machine; they need to perform a valuable, useful service that benefits the organization as a whole. Reed, the director […]

Categories
business healthcare

Healthcare Leadership: Pharmacy Practice Training: Methods and Effectiveness

The pharmacy field is constantly changing and is a career that is currently in high demand. More pharmacy schools are being built and hold the responsibility of training the pharmacists of the future. Due to accreditation standards set by the Accreditation Council for Pharmacy Education (ACPE), programs are expected to have their students complete Introductory […]

Categories
business healthcare

Healthcare Leadership: Hospital Pharmacy: Leadership Training

Good leadership starts at the hiring process. Organizations need employees that independently lead but also follow their managers. In order for managers to hire leader-worthy employees, the hiring process should be reexamined, modified, and improved (O’Connor, 2013). O’Connor (2013) says that “process change comes from the bottom-up, but culture change moves from the top-down” (p. […]

Categories
business healthcare

Healthcare Leadership: Hospital Pharmacy: Background

“I would prefer to spend time discussing briefly our greatest need in hospital pharmacy – leadership” (Francke, 1955). The need to discuss pharmacy leadership is still relevant today. There is a great lack of leadership that still exists in the pharmacy profession. Leadership comprises capacity, goals, and efficacy. Hospital organizations are unique because they are […]

Categories
drugs healthcare

Patent Sovereignty: Building Fortresses and Indian Tribes

In an increasingly competitive landscape, pharmaceutical companies are finding creative ways to protect their patents. Most of the time, patents are the only things that protect a company from direct competition. If a drug is successful but still protected under a patent, other companies prepare their chemical synthesis manufacturing capabilities to be able to take […]

Categories
healthcare

Single Payer: Case Studies

Not all single payer systems are designed and deployed the same. Varying degrees of private insurance involvement, system funding via taxes, and coverage limits make the system customized to meet the needs of the constituents. Canada is often used as the model example of a single payer system since it shares a border with the […]

Categories
healthcare

Single Payer: Complex Systems

The United States has an extremely complex healthcare system that’s comprised of conflicting ideologies. Private insurance, federally-funded Medicare, and state-funded Medicaid are all available for Americans. However, there are still 28 million people who do not have any kind of insurance (Carroll & Frakt, 2017). The positive thing that comes from this mix of systems […]

Categories
healthcare

Single Payer: Insurance Reform

The largest line item in the 2016 national healthcare budget was $1 trillion for hospital care which comprised of $670 billion for clinician services and $360 billion for drugs (Topol, 2017). Add in the fact that one in four patients are harmed while in the hospital and it’s easy to see that the American Healthcare […]

Categories
drugs healthcare

Drug Prices: The Solution

If the system isn’t entertaining a solution to decrease drug costs, a solution can be implemented to decrease medical costs which will decrease prescription costs. Dr. Barbara McAneny, CEO of the New Mexico Cancer Center, has demonstrated that it’s possible to decrease costs while improving patient care. Appropriately prioritizing care via comprehensive triage and treatment […]

Categories
drugs healthcare

Drug Prices: Blame Regulation

Some argue that it was too much regulation, not too little regulation that has caused the FDA to reject competing drugs due to existing patents. In a sense, this is good so that pharmaceutical companies can recoup R&D costs to create new drugs. On the other hand, the patients need to be able to afford […]

Categories
drugs healthcare

Drug Prices: Blame the PBM

Some critics of industry prices think the high prices are due to pharmacy benefit managers (PBMs). PBMs are essentially the middleman between the pharmacy and the drug manufacturer. However, as Tim Wentworth, a CEO from Express Scripts states, “Drug makers set prices, and we [the PBM] exist to bring them down” (Weinberg & Langreth, 2017). […]

Categories
drugs healthcare

Drug Prices: The Convoluted Insulin Monopoly

Looking back in time, it’s mind-boggling to think about how Big Pharma pricing became so far out of control. Insulin therapy, presently in mainstream high supply and demand, used to be a cutting-edge treatment that was difficult to create. The three person team that created a way to generate insulin recognized the need for this […]

Categories
drugs healthcare

Drug Prices: Epi-Pen

A very recent point of contention is the price of Epi-Pens® (Mylan). Epi-Pens® save the lives of people who experience anaphylactic shocks. Due to numerous petitions, Mylan claims that they dropped the price of the Epi-Pen®. But in reality, Mylan simply offered a $300 savings card to underinsured consumers (“The Other 98%”, 2017). Everyone else, […]

Categories
drugs healthcare

Drug Prices: Trends

The world’s most expensive drug, as of 2016, is Soliris® (Alexion Pharmaceuticals) being priced at $409,500 a year per patient. The disease that this drug treats only affects 8,000 Americans, but the drug maker generated $295 million in one year for that one drug (Herper, 2010). Turing Pharmaceuticals raised the price of an anti-infection drug […]

Categories
business technology

New Collar Jobs and Future Aspirations amidst Uncertainty

During the 2017 transition of political power in America, there were many unanswered questions surrounding the future climate of technology, businesses, and jobs. IBM, a company that has been around for 105 years, has seen many periods of change and uncertainty. Education, IT infrastructure, and healthcare are important passions of IBM. There is no other […]

Categories
business technology

Robot Takeover

In the technology circuit, there have been debates and concerning discussions on the implications of robots, or artificial intelligence, gaining abilities and power. Concerns of ethics, privacy, and job availability have stemmed from the increasing abilities of these technologies. IBM CEO Ginni Rometty is convinced that Watson and other cognitive computing platforms will not lead […]

Categories
business technology

Artificial Intelligence and Cognitive Systems

The capabilities of IBM’s cognitive system platform, Watson, is endless. IBM is working on developing it as a service that it can sell. It runs on an Application Programming Interface (API) housed in the IBM Public Cloud where users can manipulate the code via system tools (Chafkin, 2016a). Artificial intelligence is just one of the […]

Categories
business technology

Ginni Rometty of IBM and Shifts in Technology

International Business Machines (IBM), also known as “Big Blue”, is a technology company that has been around for a long time and has survived numerous changes in technological trends and advancements. The current CEO, Ginni Rometty, was in the spotlight at the turn of the first quarter of the 21st century. As the first woman […]

Categories
business

Business Leadership: Methods: Thought Leadership

Goleman states that there are three kinds of performance-based classifications in a team setting: poorly performing, well performing, and superlative teams. The poorly performing team is limited by its individual average. The well performing team performs above average. But a superlative team performs better than the best member of the team. Superlative teams work synergistically. […]

Categories
business

Business Leadership: Methods: Emotional Leadership

The “Emotional Intelligence of Leaders”, a piece by Daniel Goleman, explores the association between emotional intelligence and a leader’s ability to effectively manage their organization. Goleman acknowledges that both intelligence and credentials are essential to business management and leadership, but one cannot overlook the importance of empathy and emotions. These latter aspects are needed because […]

Categories
information technology

Security: Technology, Law, and Privacy

Technology seems to operate in a separate universe that doesn’t have to abide by the law. Technology companies are adamant that they are not legally responsible for the harm their services can cause or the activities of their users (“Eroding Exceptionalism”, 2017). Having to monitor their users would be difficult and costly to these companies. […]

Categories
information technology

Security: Protection in the Cloud

Cloud computing is still an ambiguous buzzword. Each major technology company defines it a little differently (Luqmani, 2014). NIST defines cloud computing as a model for enabling convenient, on-demand network access to a shared pool of computing resources. IBM views cloud computing as cost-efficient model for distributing processes, applications and services while simplifying IT management […]

Categories
information technology

Security: Internet Regulation

Who owns the internet? Perhaps the people do as they are the ones generating the content. Perhaps it’s the government of various countries as they have the power to regulate what is able to be published. Countries are adopting different approaches of regulating the internet depending upon their societal and cultural values (Lawrence, Culjak, & […]

Categories
information technology

Artificial Intelligence and Augmented Reality

“Internet of Things”, “Artificial Intelligence”, and “Big Data” may seem like synonymous, buzzwords on the surface, but in reality, their stark differences allude to their similarities. These three concepts are re-writing how we interact, buy and sell, travel, and make things (Brody, 2016). Products such as 3D printers, smart lightbulbs, smart slow cookers, and smart […]

Categories
healthcare technology

Healthcare and Applications of IoT

Adherence to treatment is a major issue in the healthcare field. Technology can help with it. There are many different systems that store medical and nonmedical information. Claim data can be very helpful, but it’s reactive in the sense that it’s historical and occurs after the medical event. Integrating formulary, cost, benefit, and EHR information […]

Categories
healthcare system

Healthcare System: Increasing and Unavoidable System Complexity

As companies grow and expand, they acquire and merge with information systems. Each time an additional system gets added or a system’s capabilities expand, the complexities and intricacies subsequently increase. Samuel Arbesman believes that system complexity is not a good or bad thing, but rather an inevitable thing (Lucky, 2017). He believes that everything done […]

Categories
healthcare system

Healthcare System: Value and Sustainability

The current healthcare system is unsustainable in terms of affordability, quality, accessibility, and personalization. There are three broad tasks that can improve the current system: expand choice, improve affordability and quality, and speed up the conversion of volume to value. Value is important in any business model (Osterwalder, Pigneur, & Clark, 2010). It’s the “difference […]

Categories
healthcare system

Healthcare System: Ideal State: Delivery of Care

A Walmart greeter welcomes the customer, engages with him/her, and guides him/her in the right direction. A top health executive for a giant retail chain advocates that this is how health plans should operate (Osbourne, 2016). As health plans sit opportunistically in the middle of patients, doctors, and pharmacists, they’re in the perfect position to […]

Categories
healthcare system

Healthcare System: Current State: System Failure

One example of a system failure is the American Opioid Epidemic. Health plans commonly make it harder for patients to fill more expensive, less addictive pain management drugs (Volkow, 2016). They do this by requiring prior authorization, quantity limits, and contingent therapies. These restrictive measures are set on the plan’s formulary and essentially drowned prescribers […]

Categories
drugs

American Opioid Epidemic: Future Recommendations

Substance abuse disorders were always undertreated. Although there has been an improvement in treatment due to increased education and research, there is still more that can be done. Only 10% of substance abuse patients receive specialized treatment (U.S. Department of Health and Human Services, 2016). Over 40% of patients with a substance abuse disorder also […]

Categories
drugs

American Opioid Epidemic: Not Helping the Crisis

The prescribing of fentanyl is highly regulated by the FDA as it’s a scheduled II drug. This means that it’s rather addictive and subject to abuse. Some pharmaceutical companies are seeking to enter this market by formulating the drug in different forms of administration (ie: spray, injection, oral, etc.). Michael Babich from Insys Therapeutics was […]

Categories
drugs

American Opioid Epidemic: Action Taken

In 2017, the FDA restricted the manufacturing of Schedule II Opiates by 25%. Obviously the FDA has a critical role in controlling the manufacturing quotas of Schedule I and II substances. When setting quotas, the institution did their due diligence in reviewing: Estimates of the legitimate medical need Estimates of retail consumption based on prescriptions […]

Categories
drugs

American Opioid Epidemic: The Start

The American Opioid Epidemic was a major topic of discussion of the twenty-first century. Opioid pain medication was being prescribed left-and-right. Initially, prescribers were being coached to prescribe more pain medication as pain was being greatly undertreated in patients. This was demonstrated in James Campbell’s presidential address of the American Pain Society where he stated […]

Categories
drugs

Drug Approvals: Value-based Contracting

Value-based contracting helps hold Big Pharma accountable. If the drug shows a lack of clinical effectiveness and/or results in unreported side effects, the manufacture owes the plan sponsor two-thirds of the drug’s cost. Rishi Manchanda, the Chief Medical Officer (CMO) of The Wonderful Company, believes that the sequel to the triple aim is the quadruple […]

Categories
drugs

Drug Approvals: Biosimilar Drugs

Biosimilar drugs are identical copies of a product that has an expired patent. They are expected to increase competition and reduce drug prices. Europe, Canada, Japan, and Australia have sold dozens of biosimilar drugs for ten years. In the US, prices are expected to drop by 35%. In addition, $80 billion in sales will lose […]

Categories
drugs

Drug Approvals

Big Pharma is a dynamic and complex industry. Just a few of the stakeholders include researchers, drug companies, pharmacies, governmental agencies, health plans, doctors, and patients. Agencies such as the Food and Drug Administration (FDA), National Institutes of Health (NIH), Department of Health, and the Drug Enforcement Agency (DEA) have much influence on the pharmaceutical […]

Categories
drugs

Antibiotic Shortage: Limiting Access to Increase Profit

Views on antibiotics have changed over the years. It used to be that the standard was to have doctors prescribe antibiotics for the littlest ailments. Now, doctors are to be more cautious when prescribing antibiotics and only prescribe them if it’s absolutely necessary. For antibiotics, it’s beneficial for pharmaceutical companies to limit the drug’s effectiveness […]

Categories
drugs

Big Pharma Corruption: Placebos

Placebos are commonly viewed as fraud among the general public. Some news stories have said that some drugs that were sold as prescriptions were just milk and sugar. Although it is wrong to sell placebos in place of real drugs, placebos have a great deal of importance in pharmaceutical research. Placebos can make a control […]

Categories
drugs

Big Pharma Corruption: Clinical Trials Gone Wrong

The sneaky relationship between researchers and drug companies taint the trials and therefore put the patient in danger. Borison and Diamond, two psychiatrists from the Medical College of Georgia, are in jail because of endangering the safety of multiple patients by tainting trials of over twenty drugs in order to receive hundreds of thousands of […]

Categories
drugs

Big Pharma Corruption: Drug Design and Designer Drugs

Over the past five years, debates about designer drugs have been growing. This new sector’s main focus is to genetically alter drugs so that they are custom for the individual patient. Although in theory this sounds like a health-improving technology, the failure of the multiple companies to agree on a destination and move forward is […]

Categories
drugs

Big Pharma Corruption

Big Pharma, the name we collectively attach to all of the drug companies, has been under scrutiny for the past few decades. The government, healthcare institutions, and drug companies collaborate together to supposedly provide us with the finest drugs for our consumption to maintain or improve our health. Peter Coy puts it perfectly, Big Pharma […]

Categories
drugs

Drugs: The Gap Between Law and Health

Kratom is a green leaf of a tree of the coffee family. It’s been used for centuries in Indonesia, Malaysia, and Thailand. The leaf has been gaining popularity in the US, but not for the original use of boosting energy. Taking 2-3 grams of Kratom is said to induce euphoria and reduce pain while not […]

Categories
information

Information Access

“We’re just getting started on our goal of connecting everyone.” That’s the goal of Facebook’s founder, Mark Zuckerberg. I share that vision. Information should not be something that only privileged students or wealthy people have access to. It should be provided to everyone whether it’s in the form of electronic devices or printed material, social […]

Categories
Uncategorized

Initial, Future State

We cannot move forward in a positive, productive fashion if we don’t fully understand the present. I aim to paint an accurate, unbiased picture of the present world so that we can decide if we need to move forward as is, or move forward with change. And if we need change, what kind of change […]